Zofia E. Dziewanowska

Overview

Zofia E. Dziewanowska received an average of $663K in total compensation, including $331K in salary, at Ligand Pharmaceuticals between 2007 and 2008.

Source: SEC filing on April 29, 2009.

Related executives

We found eight more executives who work or worked at Ligand Pharmaceuticals.

John Higgins

Ligand Pharmaceuticals

Chief Executive Officer

Matthew Korenberg

Ligand Pharmaceuticals

Chief Financial Officer

Matthew Foehr

Ligand Pharmaceuticals

Chief Operating Officer

Charles Berkman

Ligand Pharmaceuticals

General Counsel

Nishan de Silva

Ligand Pharmaceuticals

Chief Financial Officer

Melanie Herman

Ligand Pharmaceuticals

Chief Financial Officer

John Sharp

Ligand Pharmaceuticals

Chief Financial Officer

Martin Meglasson

Ligand Pharmaceuticals

Vice President, Discovery Research

You may also like